MINNEAPOLIS--(BUSINESS WIRE)--Possis Medical, Inc. (NASDAQ: POSS), a developer, manufacturer and distributor of pioneering medical devices used in endovascular procedures, announced today that it will report complete results for its second quarter ended January 31, 2008, at 7:00 a.m. (CT) on Feb. 20, 2008. Based on preliminary results, Possis indicated that it currently expects net sales of approximately $20.6 million for the second quarter, a 30 percent increase from fiscal 2007 second-quarter sales of $15.8 million. In its outlook issued on Nov. 21, 2007, the Company had estimated second-quarter net sales of $18.7 million to $19.2 million. Possis anticipates second quarter net income to fall within its previously issued guidance range of $0.03 to $0.05 per diluted share, compared to a net loss of $0.04 per diluted share in the second quarter of fiscal 2007.
